Indonesia surpasses the Philippines, the place with the most Covid-19 infections in Southeast Asia

Police asked and instructed residents to wear masks on the outskirts of Jakarta. Photo: Reuters.
Police asked and instructed residents to wear masks on the outskirts of Jakarta. Photo: Reuters.

The number of cases of Covid-19 in Indonesia so far has reached 5,923 cases, becoming the country most affected by the epidemic in Southeast Asia.

According to Channel NewsAsia, Indonesia recorded a new record of 407 new Covid-19 cases on April 17, bringing the total number of cases in the country to 5,923 cases and becoming the most heavily affected Southeast Asian country. by the disease.

Also in Indonesia, an additional 24 deaths have been recorded in the past 24 hours, bringing the number of corona virus victims in the country of thousands of islands to 520 people. There have been 607 people discharged from the hospital.

The Philippines, the country with the most previous Covid-19 cases in the region, recorded 218 more cases today, bringing the total number of cases up to 5,878.

Indonesia has witnessed a significant increase in the number of new infections over the past 2 weeks. On April 5, the country had fewer than 2,500 cases. Experts say the increase comes from efforts to increase government testing.

Until April 5, fewer than 10,000 tests were conducted nationwide, more than a month after Indonesia recorded its first Covid-19 case on March 2.

Since then, more than 30,000 tests have been performed, but the number is still too small for a country of 260 million people. Malaysia’s test rate is 2,700 per 1 million people while in Singapore it is 12,000.

A spokesman for the Indonesian government’s Special Working Group in response to the Covid-19 epidemic said the testing capacity would be improved to increase testing rates for people.

“President Joko Widodo has instructed more testing and stronger tracing,” the spokesman said at a news conference on April 17.

There are currently 34 laboratories across the country working on samples from patients as well as suspected patients. In early March, only one lab across the country did this.